In many cancers, constitutive nuclear NFκB activity has emerged as a hallmark for cancer progression including breast cancer and constitutive NFκB activity often linked to drug resistance and increased cell survival in response to genotoxic stress86. This evidence concerns the gene NFKB1 and breast cancer.